New initiatives against Africa's worms

被引:86
作者
Fenwick, A [1 ]
机构
[1] Univ London Imperial Coll Sci & Technol, Dept Infect Dis Epidemiol, London W2 1PG, England
基金
英国惠康基金;
关键词
schistosomiasis; bilharziasis; filariasis; trachoma; intestinal worms; praziquantel;
D O I
10.1016/j.trstmh.2005.03.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Since 1999, the funding available for the control of diseases of poverty (neglected diseases) has increased mainly due to leverage resulting from donations by the Bill and Melinda Gates Foundation and loans from the World Bank. Many countries have embarked on control programmes on a national scale due to drug donations by pharmaceutical companies through vertical programmes. The Schistosomiasis Control Initiative has expanded its operations to cover six countries in sub-Saharan Africa, but overlap of treatments between different vertical programmes is now a reality, and so care is needed to ensure that too many different drugs are not given together. Dialogue between programme managers has increased, and integration of some programmes may offer chances of synergy. (c) 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 45 条
[1]  
Bailey R, 2001, B WORLD HEALTH ORGAN, V79, P233
[2]  
Brieger WR, 1998, TROP MED INT HEALTH, V3, P951
[3]   Evaluating the epidemiological impact of national control programmes for helminths [J].
Brooker, S ;
Whawell, S ;
Kabatereine, NB ;
Fenwick, A ;
Anderson, RM .
TRENDS IN PARASITOLOGY, 2004, 20 (11) :537-545
[4]  
BUNDY D, 2001, ACC SCN 28 SESS NAIR
[5]   Action starts now to control disease due to schistosomiasis and soil-transmitted helminthiasis [J].
Crompton, DWT ;
Engels, D ;
Montresor, A ;
Neira, MP ;
Savioli, L .
ACTA TROPICA, 2003, 86 (2-3) :121-124
[6]   Monitoring future impact on malaria burden in sub-Saharan Africa [J].
De Savigny, D ;
Binka, F .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 71 (02) :224-231
[7]   The global epidemiological situation of schistosomiasis and new approaches to control and research [J].
Engels, D ;
Chitsulo, L ;
Montresor, A ;
Savioli, L .
ACTA TROPICA, 2002, 82 (02) :139-146
[8]   Drugs for the control of parasitic diseases: current status and development in schistosomiasis [J].
Fenwick, A ;
Savioli, L ;
Engels, D ;
Bergquist, NR ;
Todd, MH .
TRENDS IN PARASITOLOGY, 2003, 19 (11) :509-515
[9]   Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis [J].
Hall, A ;
Nokes, C ;
Wenz, ST ;
Adjei, S ;
Kihamia, C ;
Mwanri, L ;
Bobrow, E ;
de Graft-Johnson, J ;
Bundy, D .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (06) :653-658
[10]   Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania [J].
Hatz, CF ;
Vennervald, BJ ;
Nkulila, T ;
Vounatsou, P ;
Kombe, Y ;
Mayombana, C ;
Mshinda, H ;
Tanner, M .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 59 (05) :775-781